The nation's pharmaceutical laboratories, the FDA, and many other regulator
y bodies are drowning n paper. The FDA's recently introduced Electronic Rec
ords and Electronic Signatures Rule (21 CFR Part 11) was intended to improv
e productivity, but complying with the new rule is not a simple task.